Citation: | TANG Lu, HU Liping, LI Qingjiao, CAI Hua. Effect of early time-restricted feeding on vitamin D and glycolipid metabolism in overweight/obese patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 127-132. DOI: 10.7619/jcmp.20232294 |
To explore the early time-restricted feeding (e-TRF) on serum vitamin D level and glycolipid metabolism in overweight/obese patients with polycystic ovary syndrome (PCOS).
A total of 35 overweight/obese patients with PCOS were publicly recruited for treatment of 4-week e-TRF dietary intervention in the body quality management clinic of authors' hospital. Before and after intervention, the human body composition analysis and blood sampling tests (serum vitamin D level and biochemical indicators related to glucose and lipid metabolism) were conducted, and changes in various indicators were compared.
After 4 weeks of e-TRF intervention, the level of vitamin D in 35 patients increased significantly, and the ratios of cases with vitamin D deficiency or insufficiency decreased significantly (P < 0.01). In the indicators of glucose and lipid metabolism, the levels of glycated hemoglobin, fasting blood glucose, fasting insulin, insulin resistance index, total cholesterol, triglycerides and low-density lipoprotein cholesterol decreased significantly after intervention when compared to those before intervention, while the level of high-density lipoprotein cholesterol increased significantly when compared to that intervention before (P < 0.05). After intervention, the vitamin D level was significantly negatively correlated with body weight, body mass index, hip circumference, fasting insulin, insulin resistance index and triglycerides (r=-0.451, -0.352, -0.424, -0.543, -0.491, -0.394, P < 0.05).
The e-TRF can increase vitamin D level in overweight/obese patients with PCOS in a short period of time (4 weeks), reduce body mass, and improve glucose and lipid metabolism indicators.
[1] |
中国医师协会内分泌代谢科医师分会. 多囊卵巢综合征诊治内分泌专家共识[J]. 中华内分泌代谢杂志, 2018, 34(1): 1-7.
|
[2] |
ESCOBAR-MORREALE H F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment[J]. Nat Rev Endocrinol, 2018, 14(5): 270-284. doi: 10.1038/nrendo.2018.24
|
[3] |
WU Q, GAO J, BAI D X, et al. The prevalence of polycystic ovarian syndrome in Chinese women: a meta-analysis[J]. Ann Palliat Med, 2021, 10(1): 74-87. doi: 10.21037/apm-20-1893
|
[4] |
MU Y, CHENG D, YIN T L, et al. Vitamin D and polycystic ovary syndrome: a narrative review[J]. Reprod Sci, 2021, 28(8): 2110-2117. doi: 10.1007/s43032-020-00369-2
|
[5] |
TEEDE H J, TAY C T, JOHAM A E. Polycystic ovary syndrome: an intrinsic risk factor for diabetes compounded by obesity[J]. Fertil Steril, 2021, 115(6): 1449-1450. doi: 10.1016/j.fertnstert.2021.03.024
|
[6] |
LUMME J, SEBERT S, PESONEN P, et al. Vitamin D levels in women with polycystic ovary syndrome: a population-based study[J]. Nutrients, 2019, 11(11): 2831. doi: 10.3390/nu11112831
|
[7] |
江波, 白文佩, 郁琦, 等. 生酮饮食干预多囊卵巢综合征中国专家共识(2018年版)[J]. 实用临床医药杂志, 2019, 23(1): 1-4. doi: 10.7619/jcmp.201901001
|
[8] |
MOHAN A, HAIDER R, FAKHOR H, et al. Vitamin D and polycystic ovary syndrome (PCOS): a review[J]. Ann Med Surg, 2023, 85(7): 3506-3511. doi: 10.1097/MS9.0000000000000879
|
[9] |
MANOOGIAN E N C, CHOW L S, TAUB P R, et al. Time-restricted eating for the prevention and management of metabolic diseases[J]. Endocr Rev, 2022, 43(2): 405-436. doi: 10.1210/endrev/bnab027
|
[10] |
XIE Z B, SUN Y N, YE Y Q, et al. Randomized controlled trial for time-restricted eating in healthy volunteers without obesity[J]. Nat Commun, 2022, 13(1): 1003. doi: 10.1038/s41467-022-28662-5
|
[11] |
ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUS WORKSHOP GROUP. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(1): 19-25. doi: 10.1016/j.fertnstert.2003.10.004
|
[12] |
MIFFLIN M D, ST JEOR S T, HILL L A, et al. A new predictive equation for resting energy expenditure in healthy individuals[J]. Am J Clin Nutr, 1990, 51(2): 241-247. doi: 10.1093/ajcn/51.2.241
|
[13] |
中国营养学会. 中国居民膳食指南(2022)[M]. 北京: 人民卫生出版社, 2022: 345-346.
|
[14] |
TEEDE H J, MISSO M L, COSTELLO M F, et al. Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J]. Hum Reprod, 2019, 34(2): 388. doi: 10.1093/humrep/dey363
|
[15] |
夏维波, 章振林, 林华, 等. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS201801001.htm
|
[16] |
HOLICK M F, BINKLEY N C, BISCHOFF-FERRARI H A, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2011, 96(7): 1911-1930. doi: 10.1210/jc.2011-0385
|
[17] |
FLINT A, RABEN A, BLUNDELL J E, et al. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies[J]. Int J Obes Relat Metab Disord, 2000, 24(1): 38-48. doi: 10.1038/sj.ijo.0801083
|
[18] |
SUTTON E F, BEYL R, EARLY K S, et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes[J]. Cell Metab, 2018, 27(6): 1212-1221, e3. doi: 10.1016/j.cmet.2018.04.010
|
[19] |
KRUL-POEL Y H, SNACKEY C, LOUWERS Y, et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review[J]. Eur J Endocrinol, 2013, 169(6): 853-865. doi: 10.1530/EJE-13-0617
|
[20] |
VRANIC L, MIKOLAŠEVIC I, MILIC S. Vitamin D deficiency: consequence or cause of obesity[J]. Medicina, 2019, 55(9): 541. doi: 10.3390/medicina55090541
|
[21] |
李健, 白文佩, 江波, 等. 生酮饮食对超重/肥胖多囊卵巢综合征患者维生素D及糖脂代谢的影响[J]. 实用临床医药杂志, 2022, 26(4): 14-17, 32. doi: 10.7619/jcmp.20220496
|
[22] |
SZYMCZAK-PAJOR I, SLIWINSKA A. Analysis of association between vitamin D deficiency and insulin resistance[J]. Nutrients, 2019, 11(4): 794. doi: 10.3390/nu11040794
|
[23] |
LI C Z, XING C, ZHANG J Q, et al. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women withanovulatory polycystic ovary syndrome[J]. J Transl Med, 2021, 19(1): 148. doi: 10.1186/s12967-021-02817-2
|
[24] |
郑思岚. 限时饮食对超重/肥胖多囊卵巢综合征患者减重的随机对照干预研究[D]. 厦门: 厦门大学, 2020.
|
[25] |
ANTON S D, MOEHL K, DONAHOO W T, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting[J]. Obesity, 2018, 26(2): 254-268. doi: 10.1002/oby.22065
|
[26] |
RAVUSSIN E, BEYL R A, POGGIOGALLE E, et al. Early time-restricted feeding reduces appetite and increases fat oxidation but does not affect energy expenditure in humans[J]. Obesity, 2019, 27(8): 1244-1254. doi: 10.1002/oby.22518
|
[27] |
ANTONI R, JOHNSTON K L, COLLINS A L, et al. Effects of intermittent fasting on glucose and lipid metabolism[J]. Proc Nutr Soc, 2017, 76(3): 361-368. doi: 10.1017/S0029665116002986
|
[28] |
汪俊宇, 张安仁. 肠道菌群在间歇性禁食治疗肥胖中的作用研究[J]. 中国全科医学, 2019, 22(27): 3308-3311. doi: 10.12114/j.issn.1007-9572.2019.00.452
|
[29] |
SEIMON R V, ROEKENES J A, ZIBELLINI J, et al. Do intermittent diets provide physiological benefits over continuous diets for weight loss A systematic review of clinical trials[J]. Mol Cell Endocrinol, 2015, 418(Pt 2): 153-172.
|
[30] |
HE C L, LIN Z M, ROBB S W, et al. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis[J]. Nutrients, 2015, 7(6): 4555-4577. doi: 10.3390/nu7064555
|
[31] |
卫小静, 郭欢, 赵阳, 等. 维生素D对多囊卵巢综合征患者糖脂代谢指标的影响[J]. 中国妇幼保健, 2022, 37(20): 3692-3695. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202220003.htm
|
[32] |
MARTENS C R, ROSSMAN M J, MAZZO M R, et al. Short-term time-restricted feeding is safe and feasible in non-obese healthy midlife and older adults[J]. Geroscience, 2020, 42(2): 667-686. doi: 10.1007/s11357-020-00156-6
|
[33] |
GABEL K, HODDY K K, VARADY K A. Safety of 8-h time restricted feeding in adults with obesity[J]. Appl Physiol Nutr Metab, 2019, 44(1): 107-109. doi: 10.1139/apnm-2018-0389
|
[34] |
LOWE D A, WU N, ROHDIN-BIBBY L, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial[J]. JAMA Intern Med, 2020, 180(11): 1491-1499.
|
1. |
张媛媛,赵志杰,刘青,李鹏飞,苑文娟. 血清NT-pro-BNP、IGFBP-7和CTRP12在慢性心力衰竭患者中的水平及意义. 检验医学与临床. 2025(01): 107-111+118 .
![]() | |
2. |
陈伟光,谢冠聪,李桂云,龚宇锋,徐文波,王悦宁,许香广. 利用半乳糖凝集素-3、N末端B型利钠肽原联合超声心动图评估心力衰竭预后的研究. 齐齐哈尔医学院学报. 2022(09): 862-865 .
![]() | |
3. |
吴利杰,董发. 左卡尼汀治疗慢性心力衰竭患者的疗效及安全性. 实用临床医药杂志. 2020(02): 104-107 .
![]() | |
4. |
邓凡. BNP的检测在危重烧伤患者病情评估中的临床应用价值. 当代医学. 2020(18): 61-63 .
![]() | |
5. |
李润琴,郑晓轩,柴慧. 左西孟旦联合复方丹参滴丸治疗慢性心力衰竭的临床研究. 中国药物与临床. 2020(23): 3949-3951 .
![]() | |
6. |
孙婧,赵沱,刘亚荣. 自拟芪红汤在慢性心力衰竭患者康复治疗中的应用对心脏标记物、生活质量的影响. 四川中医. 2019(07): 86-88 .
![]() | |
7. |
林傲,孙晗嫣,孙晗然,吕焕然,张钧宇,魏艳丽,王凤玲,黄佳滨. 半乳凝素3与超敏C反应蛋白在老年舒张性心力衰竭的相关性研究. 黑龙江医药科学. 2019(03): 45-46 .
![]() | |
8. |
李振超. IL-27、树突状细胞在慢性心力衰竭患者外周血中的表达变化. 医学理论与实践. 2019(20): 3342-3343 .
![]() | |
9. |
张建霞,杨培亮,王焕. 冠心病合并慢性心力衰竭患者GDF15、BNP、sST2的表达及其与心功能的相关性. 临床误诊误治. 2019(12): 67-71 .
![]() | |
10. |
盛洋,郑学敏,王伟,沈盛晖. 酒石酸美托洛尔片联合左卡尼汀注射剂治疗慢性心力衰竭的临床研究. 中国临床药理学杂志. 2018(04): 410-413 .
![]() | |
11. |
邓威. 血清Gal-3、NT-pro-BNP在慢性心力衰竭中的表达及临床意义. 中国民康医学. 2018(16): 20-21 .
![]() |